Berberine alleviates early brain injury after subarachnoid hemorrhage by inhibiting GSK3β-mediated CASP1-dependent pyroptosis

Key Points

• Berberine reduces early brain injury caused by subarachnoid hemorrhage, providing protective effects against neuronal damage.
• Key evidence shows that treatment with berberine significantly lowers CASP1 activation and pyroptosis levels, underscoring its therapeutic potential.
• Analysis highlighting the role of GSK3β inhibition in attenuating inflammatory processes linked to early brain injury, making it a crucial target.
• This study implies a promising avenue for new treatments for brain injury, calling for further exploration of berberine's potential in clinical applications.